Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs >

Amarantus BioScience Holdings, Inc. (AMBS)

AMBS RSS Feed
Add AMBS Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade, r00kie, joboggi, Sir Francelote, guardiangel, Rosym
Search This Board:
Last Post: 8/27/2014 10:32:36 AM - Followers: 717 - Board type: Free - Posts Today: 11


Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. The company has licensed Eltoprazine, a Phase 2B ready Parkinsons Levadopa induced Dyskinesia. The company has an exclusive worldwide license to the Lymphocyte Proliferation test ("LymPro Test®") for Alzheimer's Disease and owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. Amarantus is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property rights for the diagnosis of Parkinson's Disease ("NuroPro") and the discovery of neurotrophic facotrs ("PhenoGuard"). For furtherinformation, please visit www.Amarantus.com, or connect with the company on Facebook, LinkedIn, Twitter and Google+

 

TRANSFER AGENT
Stock Transfer, LLC
77 Spruce Street, Suite 201
Cedarhurst, NY 11516
Attention:
Yoel Goldfeder
Phone: 212-828-8436
Toll-Free: 855-9VSTOCK
Fax: 646-536-3179




 

DAILY CHART - click this link to view

 

EDGAR (SEC) FILINGS  - click this link to view

 

                                           PRESS RELEASES & NEWS ARTICLES

Amarantus Reports Second Quarter 2014 Financial Results, Announces Business Update Call
Aug. 27, 2014   Today
Amarantus to Present at Upcoming Investor Conferences
Aug. 19, 2014   8:42 A.M. EDT
Amarantus Exercises Option to License Intellectual Property From University of Miami Bascom Palmer Eye Institute for Use of MANF in Retinal Disorders
Aug. 15, 2014   8:11 A.M. EDT
Amarantus BioScience Holdings, Inc. "Preparing Amarantus for the Up-list in 2H-14: Capital Markets Strategy"
Aug. 11, 2014   8:03 a.m. EDT
Amarantus Enters Into Research Collaboration With the Buck Institute for Research on Aging for MANF
Aug. 11, 2014   8:01 A.M. EDT
OTC Trading Stock News: Amarantus Biosciences Holdings, Inc. Virtus Oil and Gas Corp, Cannabis Sativa, Inc. Creative Edge Nutrition, Inc. DNA Brands, Inc.
Aug. 5, 2014   8:00 A.M.EDT. 
Amarantus BioScience Holdings, Inc. - "#C4CT Wrap-up and the Decision to Present Interim LP-002 Data"
Aug. 4, 2014   4:26 P.M.. EDT
#C4CT Summit Explored Emerging Theories on Traumatic Brain Injury, Chronic Traumatic Encephalopathy and Possible Links to Alzheimer's Disease
Aug. 4, 2014   8:00 A.M. EDT
Amarantus Announces Positive Top-Line Interim Clinical Data for Alzheimer's Blood Diagnostic LymPro Test(R)
Aug. 1, 2014   9:25 A.M. EDT
Amarantus Acquires Exclusive Option to License Alzheimer's Therapeutic IP of Dr. Thomas Arendt From University of Leipzig
Aug. 1, 2014   8:01 A.M. EDT


    •  
       

VIDEOS/AUDIO

Amarantus at LD Micro 6th Annual Conference, December 3, 2013
 

May 21, 2014

May 21, 2014
http://www.youtube.com/watch?v=oFJgCQbgdxIheartyes



 



Medical Dictionary (some often-used terms in AMBS PRs)

The substania nigra is an area of pigmented cells in the midbrain which is responsible for producing the neurotransmitter dopamine. This section of the brain plays an important role in the control of movement, and it also appears to interact in the process of addiction, as well. If you view a brain in cross-section, the substantia nigra is located in the midbrain, right at the tip of the brainstem.

The striatum is also called the striate body. It includes the caudate nucleus and the lentiform nucleus. The term striatum (striate) refers to the layered appearance of bands of gray matter that course from one of these nuclei to the other and represent the connections between them.

In living tissues, reinnervation describes the process by which post-synaptic neurons form new synapses or increase existing synaptic efficacy in order to compensate for a lack of pre-synaptic input from dead or otherwise dysfunctional pre-synaptic neurons.


Glial cell-derived neurotrophic factor, also known as GDNF is a protein that, in humans, is encoded by the GDNF gene.[1] GDNF is a small protein that potently promotes the survival of many types of neurons.[2

Myocardial infarction (MI) or acute myocardial infarction (AMI), commonly known as a heart attack

---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Pertinent Terms of Service

A. Is unlawful, threatening, abusive, harassing, defamatory, libelous, vulgar, hateful, deceptive, fraudulent, invasive of another's privacy, tortious, contains explicit or graphic descriptions or accounts of sexual acts (including but not limited to sexual language of a violent or threatening nature directed at another individual or group of individuals), or otherwise violates our rules or policies; This includes signatures as well. 
B. Attacks, verbally or otherwise, any other user, the website, any non-public figure, or any agents or employees of iHub; This includes signatures as well. 
C. Victimizes, harasses, degrades, or intimidates an individual or group of individuals on the basis of religion, gender, sexual orientation, race, ethnicity, age, or disability; This includes signatures as well. 

             A reminder, if your post is removed and you think it should be restored go to mailbox, and then click on removed posts, and follow the directions. Post that talk about other members, or other companies violate the TOS. Those posts are routinely deleted. It is easy to talk about AMBS without talking about the posters or in most cases, other companies and products.


http://stockcharts.com/h-sc/ui?s=AMBS&p=D&b=5&g=0&id=p85835636952
 


 Gerald Commissiong, President and CEO, is scheduled to present to investors at the 16th Annual Rodman & Renshaw Healthcare Conference to be held September 8-10, 2014 at the New York Palace Hotel in New York City. The presentation is scheduled for Tuesday, September 9th at 2:30 PM ET and will be web cast live, please visit the Company's IR Events section to participate. Additional information about the conference can be found at  http://www.rodm.com/.

Mr. Commissiong is also scheduled to present at the Aegis Capital Healthcare and Technology Conference to be held at the Wynn Las Vegas on September 10-13, 2014. His presentation will take place on Thursday, September 11th at 2:30 PM PT. Conference information may be found at  http://www.meetmax.com/sched/event_25932/~public/conference_home.html?event_id=25932.

Amarantus will also be participating in the First Annual Zacks Healthcare Meetup on Monday, September 8th.

Attendees who wish to meet with management one on one may contact the conference organizers or our Investor Relations department at  ir@amarantus.com


 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMBS
Current Price
Volume:
Bid Ask Day's Range
Wiki
AMBS News: Proxy Statement (definitive) (def 14a) 08/19/2014 04:55:16 PM
AMBS News: EDISON EQUITY RESEARCH - AMARANTUS BIOSCIENCE 08/19/2014 01:28:24 PM
AMBS News: Quarterly Report (10-q) 08/15/2014 04:14:47 PM
AMBS News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 08/14/2014 05:20:01 PM
AMBS News: Current Report Filing (8-k) 08/11/2014 05:15:32 PM
PostSubject
#107220  Sticky Note About Amarantus BioScience, Inc. Rosym 08/07/14 04:32:28 PM
#104968  Sticky Note MJFF is firm with their notion that NFs joboggi 07/17/14 02:01:07 AM
#104282  Sticky Note Complete Listing of Gerald's Response to Questions (Twitter 7/10/14) r00kie 07/10/14 07:59:21 PM
#104067  Sticky Note That's not what it says. It modifies barcode27 07/08/14 03:23:31 PM
#108141   an astute attorney would use this word and JPetroInc 08/27/14 10:32:36 AM
#108140   I hope you are right and I am Angry Goat 08/27/14 10:13:32 AM
#108139   I do not share your same pessimistic sentiment Sir JPetroInc 08/27/14 09:53:52 AM
#108138   I suggest you buy a few shares today. Solantey 08/27/14 09:53:00 AM
#108137   this time around i think you are wrong...you Alapis 08/27/14 09:48:04 AM
#108136   So the company ANTICIPATES to release certain info Angry Goat 08/27/14 09:45:46 AM
#108135   either this is the biggest SCAM ever or Alapis 08/27/14 09:38:17 AM
#108134   am i dreaming ? they released 2Q last Alapis 08/27/14 09:25:43 AM
#108133   NEWS OUT- hnbadger1 08/27/14 09:08:42 AM
#108132   Amarantus Reports Second Quarter 2014 Financial Results, Announces abbey1212 08/27/14 09:08:20 AM
#108131   Chasing the cure for Wolfram syndrome - MANF zoomboom 08/27/14 08:53:15 AM
#108130   many thanks.... JPetroInc 08/26/14 08:29:18 PM
#108129   That is true. sharpei 08/26/14 07:46:29 PM
#108128   Exactamundo ! Go ambs shamalam 08/26/14 02:45:28 PM
#108127   For the newbies - for the seasoned Longs JPetroInc 08/26/14 02:31:28 PM
#108126   Interesting.. thanks giannerp 08/26/14 02:28:06 PM
#108125   There was an MACD crossover. So the pps joboggi 08/26/14 12:15:30 PM
#108124   Again AMBS MANF Tool Box - remember the zoomboom 08/26/14 11:47:13 AM
#108123   "According to Dr. Lowe, "MANF is far superior itwentdwnhwmch 08/26/14 11:28:38 AM
#108122   "Direct brain infusion of glial cell line-derived neurotrophic JPetroInc 08/26/14 10:55:00 AM
#108121   ....hopefully in a GOOD way... Trashboy 08/26/14 10:44:04 AM
#108120   Sept going to be a big game changer myersvodka 08/26/14 10:31:26 AM
#108119   believe me GC will have excuses when it Alapis 08/26/14 09:44:51 AM
#108118   I believe the pressure to uplist and access dshade 08/26/14 08:58:34 AM
#108117   Incentives for orphan drug developers JPetroInc 08/26/14 08:40:04 AM
#108116   Their "executive compensation" is already absurd. Sccrbrg 08/26/14 01:41:40 AM
#108115   Fair enough... appreciate the push... time to deliver macnqueso 08/25/14 09:42:16 PM
#108114   So you have sold you ambs holdings and xxxxxl 08/25/14 09:30:38 PM
#108113   Exactly, that is why i am holding onto xxxxxl 08/25/14 09:16:08 PM
#108112   What about their push for Orphan Designation for. JPetroInc 08/25/14 09:11:58 PM
#108111   Question :why would all these qualified individuals sign keywest 08/25/14 09:02:03 PM
#108110   I believe you are a reasonable person and macnqueso 08/25/14 08:49:38 PM
#108109   The company has had no money to initiate Angry Goat 08/25/14 08:43:44 PM
#108108   an excellent question... like you i find myself macnqueso 08/25/14 08:35:26 PM
#108107   Will you please explain. Thanks klouis 08/25/14 03:23:24 PM
#108106   this isn't volatile..just hasn't reached any of the AztecJames 08/25/14 03:07:59 PM
#108105   I will not bash this. It has just docoroc2 08/25/14 02:38:39 PM
#108104   Many have become millionaires already! sumotrader 08/25/14 12:44:32 PM
#108103   I think, you make a good point. AGain christjamin 08/25/14 11:47:39 AM
#108102   IMO there is more going on here and brharris 08/25/14 10:56:06 AM
#108101   "Between the warrants and the Lincoln Park Capital JPetroInc 08/25/14 10:02:51 AM
#108100   Actually, I sold my entire position. Had to docoroc2 08/25/14 09:52:30 AM
#108099   LymPro = gold Standard. AMBS - BD replicated zoomboom 08/25/14 08:18:03 AM
#108098   I look at it this way, a positive joboggi 08/25/14 07:19:37 AM
#108097   dsw It is very probable. The pps guardiangel 08/24/14 11:00:45 PM
#108096   "Of greatest note in this preliminary proxy statement JPetroInc 08/24/14 07:03:29 PM
#108095   Patiently waiting and ignoring the noise. Seriously thinking TekNerd 08/24/14 07:00:35 PM
#108094   I am long AMBs and and believe in christjamin 08/24/14 06:34:56 PM
#108093   Still here. Waiting for major news. It will klouis 08/24/14 05:49:57 PM
#108092   After the 20:1 RS for the uplist $7.00 dsw 08/24/14 04:14:19 PM
PostSubject